patent for semaglutide Semaglutide's expires today. What does it mean patients, pharma players and Novo Nordisk? Ozempic's Key Molecule To Go

A randomized controlled clinical trial shows once-weekly semaglutide, when added to cognitive behavioral therapy, significantly reduces heavy drinking days in patients with alcohol use disorder and obesity

Here, we report the identification of a tripeptide with significant potential to treat T2D

Dividends History for Roundhill GLP-1 & Weight Loss ETF (WKN A40FEM, ISIN US77926X8829): all Ex Dates, Pay Dates, Payouts and Splits.

Stopping GLP-1 therapy requires a thoughtful plan

The news that everyone has wanted to hear is done...this product will change the face of the supplements forever

This paper advances a testable hypothesis: reductions in food noise may shift the balance of activity among DMN, salience, and executive networks in ways that support more adaptive forms of prospection